Substance Abuse Pre-Treatment Screening Study
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Feb 21, 2007
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the Substance Abuse Pre-Treatment Screening Study**
This clinical trial is designed to help people who are struggling with substance abuse, including issues with cocaine, opiates, and alcohol. The main goal of the study is to create a simple and efficient way for individuals to get the right treatment and find the best clinical trial that fits their needs. By bringing everyone together for a consistent screening process, the researchers hope to streamline how people get help and gather important information that can improve future treatments.
If you're at least 18 years old, generally healthy, and looking for treatment for substance use, you may be eligible to participate. The study is open to anyone, regardless of gender, and aims to recruit participants for a treatment program lasting between 3 to 6 months. However, individuals who are pregnant, not actively seeking treatment, or required by a court to attend treatment cannot join. Participants can expect to go through a screening process, and if eligible, receive tailored treatment options that can support their recovery journey. This is a great opportunity to get the help you need in a supportive environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Willing and able to participate in 3- to 6-month treatment program.
- • At least 18 years of age.
- • Seeking treatment for substances of abuse including (cocaine, opiates, and alcohol).
- • Generally physically healthy.
- Exclusion Criteria:
- • Pregnant or breastfeeding.
- • Mandated by the courts/parole officers to attend treatment.
- • Not seeking treatment for substances of abuse.
- • Plans to move from the Houston area within the 3- to 6-month treatment period.
- • Seeking treatment for a substance for which the Treatment Research Clinic (TRC) has no current trial.
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Joy M. Schmitz, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Frederick G Moeller, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Angela L Stotts, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials